May 21, 2026
Strides Pharma Targets FY28 $375m–$400m U.S. Revenue
Strides Pharma Science Limited — Q4 & FY26 Earnings Call (FY ended Mar 31, 2026) 1. Overall Tone of Management: Optimistic Management repeatedly highlights “sustained improvement”...
Indian Company Investor Calls
Summaries of publicly held calls between investors and listed Indian companies
May 21, 2026
Welspun Targets 18% Equity IRR on Pune Shirur
Welspun Enterprises Limited — Q4 FY26 Earnings Call (Quarter & Year ended Mar 31, 2026) | Call held May 15, 2026 1. Overall Tone of Management:...
May 21, 2026
Lenskart FY26 Call Transcript Missing; Only Audio Filing Provided
Lenskart Solutions Limited — FY26 Earnings Call (Quarter & Year ended Mar 31, 2026) Call date referenced: May 20, 2026 (audio recording filed May 21, 2026)...
May 21, 2026
SJVN Q4 FY26: Profit hinges on PLF rising above 70%
SJVN Limited — Q4 FY26 Earnings Call (Quarter/Year ended Mar 31, 2026) 1. Overall Tone of Management: Neutral (slightly optimistic) Management highlights strong generation growth and...
May 21, 2026
Jupiter Life Line Targets Dombivli Breakeven in Two Years
Jupiter Life Line Hospitals Limited — Q4 & FY26 Earnings Call (Quarter ended Mar 31, 2026) 1. Overall Tone of Management Optimistic. Management celebrated execution (“beat...
May 21, 2026
Punjab Phase 1 Ramp-Up Drives FY27 EBITDA Target
Sanathan Textiles Limited — Q4 & FY26 Earnings Call (Quarter & FY ended Mar 31, 2026) 1. Overall Tone of Management: Optimistic Management highlights “resilient operational...
May 21, 2026
Shemaroo Q4/FY26 Call Lacks Transcript Content for Analysis
Shemaroo Entertainment Limited — Q4 & FY ended Mar 31, 2026 (Earnings call dated May 18, 2026) Note: The provided “current transcript” content contains only the...
May 21, 2026
Devyani’s KFC turnaround and Sapphire merger on track
Name of the company and period Devyani International Limited (DIL) — Q4 & FY26 Earnings Conference Call (held May 15, 2026; results for quarter ended Mar...
May 21, 2026
EU Plant 2 GMP Push Drives Akums’ FY28 CDMO Outlook
Akums Drugs & Pharmaceuticals Limited — Q4 FY26 & FY26 Earnings Call (held May 18, 2026) 1. Overall Tone of Management: Optimistic Management repeatedly emphasizes “strong...
May 21, 2026
Solara’s 65% QoQ EBITDA Growth, Ibuprofen Options Pending
Solara Active Pharma Sciences Limited — Q4 FY26 Earnings Call (quarter & year ended Mar 31, 2026; call held May 15, 2026) 1. Overall Tone of...